30 stories mentioning VODUpdated 1h ago
Every FINWIRES story that references VOD, newest first.
Vodafone (VOD) said Thursday it has taken full ownership of VodafoneThree after acquiring CK Hutchison Group Telecom's 49% stake in the firm for 4.3 billion British pounds ($5.8 billion).Vodafone said the deal was funded from its cash resources.Price: $16.10, Change: $-0.03, Percent Change: -0.19%
Vodafone (VOD) filed a registration statement Tuesday with the US Securities and Exchange Commission for the potential sale of company securities.The filing covers debt securities, warrants, and preference shares, according to the filing.The company said it intends to use net proceeds from the offering for general corporate purposes.Shares of the company were up 3.6% in Tuesday trading.Price: $16.37, Change: $+0.57, Percent Change: +3.61%
European equities traded in the US as American depositary receipts started the week slightly higher late Monday morning, rising 0.15% to 1,910.62 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by software firm SAP (SAP) and lender Banco Santander (SAN), which rose 6% and 3.5% respectively. They were followed by biotech firm Evaxion (EVAX) and biopharmaceutical company Grifols (GRFS), which increased 3.3% and 3.2% respectively.The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which fell 3% and 2.6% respectively. They were followed by brewing company Anheuser-Busch InBev (BUD) and biopharmaceutical company argenx (ARGX), which were down 1.8% and 0.7% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics (AKTX) and telecommunications operator Vodafone Group (VOD), which climbed 9.6% and 5.4% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and pharmaceutical company Silence Therapeutics (SLN), which advanced 5.2% and 4.4% respectively.The decliners from the UK and Ireland were led by oil and gas companies BP (BP) and Shell (SHEL), which dropped 2% and 1% respectively. They were followed by tobacco company British American Tobacco (BTI) and utilities company National Grid (NGG), which lost 0.6% and 0.1% respectively.
European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.69% to 1,924.81 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and petroleum refiner Equinor (EQNR), which climbed 6.8% and 4.9%, respectively. They were followed by semiconductor company Sequans Communications (SQNS) and brewing company Anheuser-Busch InBev (BUD), which advanced 4% and 2.8%, respectively.The decliners from continental Europe were led by internet browser company Opera (OPRA) and biopharmaceutical company DBV Technologies (DBVT), which dropped 3.3% and 2.9%, respectively. They were followed by telecommunications company Nokia (NOK) and software firm SAP (SAP), which lost 2.6% and 2%, respectively.The gainers from the UK were led by biopharmaceutical firm Akari Therapeutics (AKTX) and insurance firm Prudential (PUK), which rose 6.6% and 3.4%, respectively. They were followed by lender HSBC (HSBC) and telecommunications company operator Vodafone Group (VOD), which were up 2.2% each.The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which shed 21% and 2.8% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and educational publisher Pearson (PSO), which fell 1.2% and 0.8% respectively.
European equities traded in the US as American depositary receipts were climbing sharply higher late Tuesday morning, rising 1.57% to 1,909.91 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and biopharmaceutical company argenx (ARGX), which rose 5.5% and 2.3% respectively. They were followed by lender Banco Bilbao Vizcaya Argentaria (BBVA)and oil and gas company Eni (E), which were up 2.2% and 0.9% respectively.The decliners from continental Europe were led by software firm SAP (SAP) and consumer goods company Unilever (UL), which fell 1.7% and 1.3% respectively. They were followed by healthcare tech company Royal Philips (PHG) and 3D printer company Materialise (MTLS), which were down 1% and 0.8%. respectivelyThe gainers from the UK were led by mining company BHP Group (BHP) and lender Lloyds Banking Group (LYG), which advanced 2.7% and 2.1%, respectively. They were followed by lender Barclays (BCS) and biotech firm Autolus Therapeutics (AUTL), which gained 2% and 0.9%, respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics (AKTX) and communications company WPP (WPP), which lost 6.3% and 4.3% respectively. They were followed by telecommunications operator Vodafone Group (VOD) and tobacco company British American Tobacco (BTI), which dropped 1.2% and 1% respectively.
European equities traded in the US as American depositary receipts were slightly lower on Thursday morning, down 0.07% to 1,911.26 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk (NVO) and drink and brewing company Anheuser-Busch Inbev (BUD), which rose 1.9% and 0.9% respectivelyThey were followed by pharmaceutical company Novartis (NVS), which added 0.8%.The decliners from continental Europe were led by tech companies Nokia (NOK) and Ericsson (ERIC), which fell 7.8% and 1.8% respectively.They were followed by bank Santander (SAN), which shed 1.5%.From the UK and Ireland, the gainers were led by advertising and PR agency WPP (WPP) and telecom giant Vodafone (VOD), which rose 3.8% and 3% respectively. They were followed by beverage company Diageo (DEO), which added 2.5%.The decliners from the UK and Ireland were led by semiconductor company Arm (ARM) and pharmaceutical company Compass Pathways (CMPS), which lost 6.9% and 2.1% respectively.
European equities traded in the US as American depositary receipts were rising on Wednesday morning, increasing 0.7% to 1,905.92 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by budget airline Ryanair (RYAAY) and health technology company Philips (PHG), which rose 3.9% and 3.8% respectively. They were followed by pharmaceutical giant Novo Nordisk (NVO) and healthcare firm Grifols (GRFS), which added 2.9% and 2.4%.The decliners from continental Europe were led by technology company Nokia (NOK) and bank BBVA (BBVA), which fell 4.7% and 1.1% respectively.From the UK and Ireland, the gainers were led by medical laboratory company Trinity Biotech (TRIB) and advertising and PR agency WPP (WPP), which rose 5.9% and 3.1% respectively. They were followed by hospitality group InterContinental Hotels (IHG), which added 1.1%.The decliners from the UK and Ireland were led by telecom giant Vodafone (VOD), which shed 2.5%, and mining company Rio Tinto (RIO), which decreased 0.6%.
European equities traded in the US as American depositary receipts fell in Monday trading with the S&P Europe Select ADR Index shedding 0.6% to 1,894.81.From continental Europe, the gainers were led by technology company Ericsson (ERIC) and healthcare company Fresenius Medical Care (FMS), which rose 2% and 1.6%, respectively. They were followed by software company SAP (SAP), which added 1.4%.The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and tech company Opera (OPRA), which fell 4.4% and 1.4%, respectively.From the UK and Ireland, the gainers were led by telecom giant Vodafone (VOD) and education group Pearson (PSO), which gained 4% and 3.2%, respectively. They were followed by energy giants BP (BP) and Shell (SHEL), which added 2.8% and 1.3%, respectively.The decliners from the UK and Ireland were led by banking group Lloyds (LYG) and pharmaceutical company AstraZeneca (AZN), which shed 1.7% and 1.1%, respectively.
European equities traded in the US as American depositary receipts were lower on Friday morning, shedding 0.2% to 1,899.89 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by steel producer ArcelorMittal (MT) and bank BBVA (BBVA), which rose 5.2% and 1.4% respectively.They were followed by technology company Opera (OPRA), which added 0.9%.The decliners from continental Europe were led by clinical-stage biopharmaceutical company Inventiva (IVA) and technology company Nokia (NOK), which fell 5.6% and 4.2% respectively.They were followed by pharmaceutical company Argenx (ARGX), which shed 3.6%.From the UK and Ireland, the gainers were led by telecom giant Vodafone (VOD) and advertising agency WPP (WPP), which rose 13% and 4.9% respectively.The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biotech company Autolus Therapeutics (AUTL), which lost 7% and 6.8% respectively.
(Updates with economic data, recent oil price movement, world markets' overview and corporate stock movements.)US equity futures were mixed pre-bell Friday as traders took note of the US market debut of South Korean chipmaker SK Hynix, while the US and Iran will continue peace talks even after an exchange of attacks in recent days.Dow Jones Industrial Average futures were 0.2% higher, S&P 500 futures were flat, and Nasdaq futures were 0.3% lower.SK Hynix's initial public offering, which consists of 177.9 million American depositary shares, raised about $26.5 billion. The sale by the South Korean semiconductor company ranks as the largest debut by a foreign firm in the US. The offer was seven times oversubscribed, with more than 500 investment firms looking to buy shares, according to a report from the Financial Times.The US will continue "technical talks" with Iran as part of peace negotiations, despite the military strikes between the two nations earlier this week, according to a report from MS Now citing a US official. President Donald Trump said that Iran's attacks on commercial vessels transiting the Strait of Hormuz were "acts of terrorism," according to the report. Trump told reporters on Thursday that Iran had reached out and wanted to make a deal to cease the escalating hostilities in the Middle East.Traders noted the latest round of earnings, with Delta Air Lines (DAL) posting lower adjusted earnings and higher revenue for Q2 while reaffirming its 2026 adjusted EPS guidance.Oil prices were higher, with front-month global benchmark North Sea Brent crude up 0.5% at $76.66 per barrel and US West Texas Intermediate crude 0.2% higher at $72.24 per barrel.The weekly Baker Hughes domestic oil-and-gas rig count is scheduled for release at 1pm ET.In other world markets, Japan's Nikkei closed 1.2% higher, Hong Kong's Hang Seng ended 0.6% higher, and China's Shanghai Composite finished 1% lower. Meanwhile, the UK's FTSE 100 was up 0.1%, and Germany's DAX index was 0.1% higher in Europe's early afternoon session.In equities, Meta Platforms (META) shares were up 3.6% after a Bloomberg report citing CEO Mark Zuckerberg as saying that the company is considering renting out some of its artificial intelligence computing capacity as demand for AI infrastructure surges. ServiceNow (NOW) stock was 1.5% higher after Hitachi Digital Services said it has launched a partnership with the company to back mission-critical infrastructure operators. Vodafone (VOD) shares rose 13% after e& Group said it has agreed to to sell its entire stake in Vodafone to Vega, an acquisition vehicle wholly owned by the Niel family group, for $5.95 billion.On the losing side, stocks of Micron Technology (MU), Intel (INTC), and Marvell Technology (MRVL) declined as part of a wider drop in semiconductor stocks. Micron shares fell 1.6%, Intel stock was 2.4% lower, and Marvell shares were down 1.3%.
European equities traded in the US as American depositary receipts were tracking lower late Wednesday morning, falling 1.11% to 1,892.74 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which rose 2.4% each. They were followed by accommodations booking site trivago (TRVG) and pharmaceutical company Ascendis Pharma (ASND), which gained 1.7% and 0.7%, respectively.The decliners from continental Europe were led by lender Banco Santander (SAN) and software company SAP (SAP), which fell 5.1% and 3.7%, respectively. They were followed by internet advertising company Criteo (CRTO) and biopharmaceutical company Cellectis (CLLS), which declined 3.5% and 1.1%, respectively.The gainers from the UK were led by oil and gas company BP (BP) and biotech company Autolus Therapeutics (AUTL), which advanced 1.7% and 1.6%, respectively. They were followed by telecommunications company Vodafone Group (VOD) and educational publisher Pearson (PSO), which each gained 0.5%.The decliners from the UK and Ireland were led by biotech company Trinity Biotech (TRIB) and pharmaceutical company Silence Therapeutics (SLN), which dropped 5.9% and 5.6%, respectively. They were followed by communications company WPP (WPP) and biopharmaceutical company Akari Therapeutics (AKTX), which fell 4.7% and 3.8%, respectively.
European equities traded in the US as American depositary receipts were heading higher late Tuesday morning, rising 0.7% to 1,919.96 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by 3D printer company Materialise (MTLS) and biopharmaceutical company Cellectis (CLLS), which rose 3.4% and 2% respectively. They were followed by telecommunications company Nokia (NOK) and petroleum refiner Equinor (EQNR), which were up 1.5% and 1% respectively.The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and consumer goods company Unilever (UL), which dropped 2.1% and 1.5% respectively. They were followed by pharmaceutical company Sanofi (SNY) and semiconductor company Sequans Communications (SQNS), which lost 1.3% each.The gainers from the UK were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and lender Lloyds Banking Group (LYG), which advanced 3% and 2.2% respectively. They were followed by software firm Endava (DAVA) and educational publisher Pearson (PSO), which increased 2% and 1.4% respectively.The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and medical device maker Smith & Nephew (SNN), which fell 5.4% each, and 3.5% respectively. They were followed by telecommunications operator Vodafone Group (VOD) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which were down 3.8% and 3.5% respectively.
European equities traded in the US as American depositary receipts started the week higher late Monday morning, advancing 0.61% to 1,903.57 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk (NVO) and telecommunications company Nokia (NOK), which rose 4.5% and 4.2% respectively. They were followed by internet browser company Opera (OPRA) and biopharmaceutical company DBV Technologies (DBVT), which were up 2.8% and 1.8% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and pharmaceutical company Sanofi (SNY), which fell 5% and 2.8% respectively. They were followed by internet advertising firm Criteo (CRTO) and semiconductor company Sequans Communications (SQNS), which were down 2.6% and 2.4% respectively.The gainers from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Amarin (AMRN), which advanced 5.7% and 4.6% respectively. They were followed by lenders Lloyds Banking Group (LYG) and Barclays (BCS), which increased 4% and 3.8% respectively.The decliners from the UK and Ireland were led by biopharmaceutical company NuCana (NCNA) and mining company BHP Group (BHP), which lost 3.1% and 2% respectively. They were followed by telecommunications operator Vodafone Group (VOD) and medical device maker Smith & Nephew (SNN), which dropped 1.8% and 0.8% respectively.
European equities traded in the US as American depositary receipts were sharply higher late Wednesday morning, rising 1.28% to 1,926.15 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by lenders Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria (BBVA), which advanced 2.5% and 2.3% respectively. They were followed by biopharmaceutical firm argenx (ARGX) and biotech firm BioNTech (BNTX), which rose 2.1% and 2% respectively.The decliners from continental Europe were led by pharmaceutical company Sanofi (SNY) and telecommunications company Nokia (NOK), which dropped 2% and 1.4% respectively. They were followed by software firm SAP (SAP) and telecommunications company Ericsson (ERIC), which were off 1% and 0.8% respectively.The gainers from the UK were led by Mereo BioPharma Group (MREO) and lender Barclays (BCS), which rose 9% and 3.6% respectively. They were followed by Akari Therapeutics (AKTX) and Bicycle Therapeutics (BCYC), which advanced 3.3% and 2.7% respectively.The decliners from the UK and Ireland were led by British American Tobacco (BTI) and telecommunications operator Vodafone Group (VOD), which fell 8% and 1.3% respectively. They were followed by oil and gas companies BP (BP) and Shell (SHEL), which were down 1.1% and 1% respectively.
European equities traded in the US as American depositary receipts started the week significantly higher late Monday morning, climbing 1.83% to 2,900.33 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by accommodations booking site trivago (TRVG) and semiconductor company Sequans Communications (SQNS), which rose 11% and 6.7% respectively. They were followed by internet browser company Opera (OPRA) and lender Banco Santander (SAN), which were up 3.3% and 2.7% respectively.The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which dropped 5.6% and 4.3% respectively. They were followed by medical device maker EDAP TMS (FOCL) and pharmaceutical company Sanofi (SNY), which were down 1.4% and 0.6%.The gainers from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Akari Therapeutics (AKTX), which advanced 3.7% and 3% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group (MREO) and Biodexa Pharmaceuticals (BDRX), which increased 2.7% and 2.3% respectively.The decliners from the UK and Ireland were led by oil and gas companies Shell (SHEL) and BP (BP), which fell 4% and 3.3% respectively. They were followed by telecommunications operator Vodafone Group (VOD) and biotech firm Trinity Biotech (TRIB), which lost 2.9% and 1.3% respectively.
Vodafone Group's (VOD) VodafoneThree has submitted a bid for TalkTalk's consumer division, the Financial Times reported on Tuesday, citing four people familiar with the matter.TalkTalk's consumer business could be worth between 200 million pounds ($268 million) and 300 million pounds, the report said, citing an estimate from New Street Research.Vodafone didn't immediately reply to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $14.84, Change: $+0.03, Percent Change: +0.17%
Correction: --VodafoneThree Submits Acquisition Bid for TalkTalk's Consumer Business, Financial Times Reports
VodafoneThree Submits Acquisition Bid for TalkTalk, Financial Times Reports
European equities traded in the US as American depositary receipts were tracking marginally lower late Thursday morning to 1,863.63 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and oil and gas company Eni (E), which rose 3.7% each. They were followed by medical device maker EDAP TMS (EDAP) and petroleum reformer Equinor (EQNR), which were up 1.3% and 0.7% respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and pharmaceutical company Novo Nordisk (NVO), which decreased 2.6% each. They were followed by software firm SAP (SAP) and biopharmaceutical company DBV Technologies (DBVT), which were down 2.1% and 1% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics (AKTX) and utilities company National Grid (NGG), which advanced 5.4% and 1.4% respectively. They were followed by tobacco company British American Tobacco (BTI) and biotech company Autolus Therapeutics (AUTL), which increased 1.3% and 0.9% respectively.The decliners from the UK and Ireland were led by software company Endava (DAVA) and telecommunications operator Vodafone Group (VOD), which lost 15.5% and 2.1% respectively. They were followed by biopharmaceutical company NuCana (NCNA) and lender Lloyds Banking Group (LYG), which were off 2% and 1.2% respectively.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our 4-STARS (Buy) recommendation, as we believe Vodafone has emerged in a much better position after portfolio rebalancing, with stabilization in Germany and improved shareholder returns of EUR3.1B in FY 26 (Mar.), with EUR1.1B in dividends and EUR2.0B in buybacks. We keep our target price at USD17, representing FY 27 consensus EV/EBITDA of 5.8x, in line with its large telco peers. We maintain our FY 27 EPS estimate at EUR1.00 and introduce our FY 28 EPS estimate at EUR1.30. In May 2026, Vodafone fully consolidated VodafoneThree in the U.K. by acquiring CK Hutchison's 49% stake for GBP4.3B, which management stated would allow for faster integration and realization of synergies. Management provided upbeat FY 27 guidance of EUR11.9B-EUR12.2B for adjusted EBITDAaL and EUR2.6B-EUR2.9B for adjusted free cash flow. We think that Vodafone will enter FY 27 with improved cash flow prospects and that the company can benefit from potential African divestments to focus on Europe, removing currency risk.
Showing 1-20 of 30
